|
Volumn 128, Issue 2, 2010, Pages 256-258
|
Propranolol for isolated orbital infantile hemangioma
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CD34 ANTIGEN;
PROPRANOLOL;
ABSENCE OF SIDE EFFECTS;
ADIPOCYTE;
ADIPOSE TISSUE;
CAPILLARY;
CASE REPORT;
CELL PROLIFERATION;
DRUG DOSE REDUCTION;
ENDOTHELIUM CELL;
EXOPHTHALMOS;
EYE BIOPSY;
EYE SURGERY;
EYELID;
FEMALE;
FOLLOW UP;
HEMANGIOMA;
HUMAN;
HUMAN TISSUE;
IMMUNOHISTOCHEMISTRY;
INFANT;
INFANT DISEASE;
LETTER;
NUCLEAR MAGNETIC RESONANCE IMAGING;
OPTIC NERVE;
ORBIT;
ORBIT TUMOR;
ORBITAL INFANTILE HEMANGIOMA;
ORBITOTOMY;
PERICYTE;
PRIORITY JOURNAL;
REPEAT PROCEDURE;
RETINA CONE;
SYSTEMIC THERAPY;
TREATMENT DURATION;
ADMINISTRATION, ORAL;
ADRENERGIC BETA-ANTAGONISTS;
FEMALE;
HEMANGIOMA;
HUMANS;
INFANT;
MAGNETIC RESONANCE IMAGING;
ORBITAL NEOPLASMS;
PROPRANOLOL;
TUMOR MARKERS, BIOLOGICAL;
|
EID: 76349096918
PISSN: 00039950
EISSN: 15383601
Source Type: Journal
DOI: 10.1001/archophthalmol.2009.375 Document Type: Letter |
Times cited : (50)
|
References (3)
|